The DOI matches its Crossref record; 371 of the 371 references it cites were found in a registry or an index.
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Open accessAbstract
Non-alcoholic steatohepatitis (NASH) is characterised by hepatic steatosis and inflammation and, in some patients, progressive fibrosis leading to cirrhosis. An understanding of the pathogenesis of NASH is still evolving but current evidence suggests multiple metabolic factors critically disrupt homeostasis and induce an inflammatory cascade and ensuing fibrosis. The mechanisms underlying these changes and the complex inter-cellular interactions that mediate fibrogenesis are yet to be fully elucidated. Lipotoxicity, in the setting of excess free fatty acids, obesity, and insulin resistance, appears to be the central driver of cellular injury via oxidative stress. Hepatocyte apoptosis and/or senescence contribute to activation of the inflammasome via a variety of intra- and inter-cellular signalling mechanisms leading to fibrosis. Current evidence suggests that periportal components, including the ductular reaction and expansion of the hepatic progenitor cell compartment, may be involved and that the Th17 response may mediate disease progression. This review aims to provide an overview of the pathogenesis of NASH and summarises the evidence pertaining to key mechanisms implicated in the transition from steatosis and inflammation to fibrosis. Currently there are limited treatments for NASH although an increasing understanding of its pathogenesis will likely improve the development and use of interventions in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–371 of 371
Role of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis
Cusi, K. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.009 · Cited by 266
Velayudham, A., Dolganiuc, A., Ellis, M., Petrasek, J., Kodys, K., Mandrekar, P., & Szabo, G. (2009) · Hepatology · doi:10.1002/hep.22711 · Cited by 263
Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9
Watanabe, A., Hashmi, A., Gomes, D. A., Town, T., Badou, A., Flavell, R. A., & Mehal, W. Z. (2007) · Hepatology · doi:10.1002/hep.21867 · Cited by 262
Wallace, K., Burt, A. D., & Wright, M. C. (2008) · Biochemical Journal · doi:10.1042/bj20071570 · Cited by 262
Higashiyama, R., Inagaki, Y., Hong, Y. Y., Kushida, M., Nakao, S., Niioka, M., Watanabe, T., Okano, H., Matsuzaki, Y., Shiota, G., et al. (2007) · Hepatology · doi:10.1002/hep.21477 · Cited by 261
Role of IL-17 and Th17 Cells in Liver Diseases
Hammerich, L., Heymann, F., & Tacke, F. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/345803 · Cited by 261
Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes
Han, M. S., Park, S. Y., Shinzawa, K., Kim, S., Chung, K. W., Lee, J.-H., Kwon, C. H., Lee, K.-W., Lee, J.-H., Park, C. K., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700184-jlr200 · Cited by 257
Alkhouri, N., Morris‐Stiff, G., Campbell, C., Lopez, R., Tamimi, T. A., Yerian, L., Zein, N. N., & Feldstein, A. E. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02639.x · Cited by 256
Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1
Jiang, G., Li, Z., Liu, F., Ellsworth, K. P., Dallas-Yang, Q., Wu, M. S., Ronan, J., Esau, C., Murphy, C., Szalkowski, D., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23962 · Cited by 255
Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
Alkhouri, N., Carter-Kent, C., & Feldstein, A. E. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.6 · Cited by 254
Sandler, N. G., Mentink-Kane, M. M., Cheever, A. W., & Wynn, T. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3655 · Cited by 251
Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome
Fessler, M. B., Rudel, L. L., & Brown, J. M. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832fa5c4 · Cited by 249
Bollheimer, L. C., Skelly, R. H., Chester, M. W., McGarry, J. D., & Rhodes, C. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci420 · Cited by 249
Athyros, V. G., Mikhailidis, D. P., Didangelos, T. P., Giouleme, O. I., Liberopoulos, E. N., Karagiannis, A., Kakafika, A. I., Tziomalos, K., Burroughs, A. K., & Elisaf, M. S. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x104696 · Cited by 248
Hepatic fibrosis and cirrhosis: The (myo)fibroblastic cell subpopulations involved
Guyot, C., Lepreux, S., Combe, C., Doudnikoff, E., Bioulac-Sage, P., Balabaud, C., & Desmoulière, A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.08.021 · Cited by 243
Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1
Jiang, G., Li, Z., Liu, F., Ellsworth, K., Dallas-Yang, Q., Wu, M., Ronan, J., Esau, C., Murphy, C., Szalkowski, D., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523962 · Cited by 241
Quantitative assessment of markers for cell senescence
Lawless, C., Wang, C., Jurk, D., Merz, A., Zglinicki, T. V., & Passos, J. F. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.018 · Cited by 240
Safadi, R., Ohta, M., Alvarez, C. E., Fiel, M. I., Bansal, M., Mehal, W. Z., & Friedman, S. L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.062 · Cited by 239
PDGF and signal transduction in hepatic stellate cells
Pinzani, M. (2002) · Frontiers in Bioscience · doi:10.2741/a875 · Cited by 239
Lalor, P. F., Edwards, S., McNab, G., Salmi, M., Jalkanen, S., & Adams, D. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.983 · Cited by 237
Facchini, F. S., Hua, N. W., & Stoohs, R. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.32403 · Cited by 233
Fargion, S. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02615-6 · Cited by 233
Seki, E., Tsutsui, H., Nakano, H., Tsuji, N. M., Hoshino, K., Adachi, O., Adachi, K., Futatsugi, S., Kuida, K., Takeuchi, O., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2651 · Cited by 231
Chen, X.-M., O’Hara, S. P., Nelson, J. B., Splinter, P. L., Small, A. J., Tietz, P. S., Limper, A. H., & LaRusso, N. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7447 · Cited by 230
Innate immunity in alcoholic liver disease
Gao, B., Seki, E., Brenner, D. A., Friedman, S., Cohen, J. I., Nagy, L., Szabo, G., & Zakhari, S. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00537.2010 · Cited by 230
Csak, T., Velayudham, A., Hritz, I., Petrasek, J., Levin, I., Lippai, D., Catalano, D., Mandrekar, P., Dolganiuc, A., Kurt-Jones, E., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00163.2009 · Cited by 229
Heydtmann, M., Lalor, P. F., Eksteen, J. A., Hübscher, S. G., Briskin, M., & Adams, D. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1055 · Cited by 226
Schnabl, B., Purbeck, C. A., Choi, Y. H., Hagedorn, C. H., & Brenner, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50097 · Cited by 224
Malaguarnera, M., Gargante, M. P., Russo, C., Antic, T., Vacante, M., Malaguarnera, M., Avitabile, T., Li Volti, G., & Galvano, F. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.719 · Cited by 223
Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity
Malhi, H., Barreyro, F. J., Isomoto, H., Bronk, S. F., & Gores, G. J. (2007) · Gut · doi:10.1136/gut.2006.118059 · Cited by 214
Guiducci, C., Tripodo, C., Gong, M., Sangaletti, S., Colombo, M. P., Coffman, R. L., & Barrat, F. J. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101048 · Cited by 214
Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics
Solga, S. F., & Diehl, A. M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00097-7 · Cited by 210
Obstructive Sleep Apnea, Insulin Resistance, and Steatohepatitis in Severe Obesity
Polotsky, V. Y., Patil, S. P., Savransky, V., Laffan, A., Fonti, S., Frame, L. A., Steele, K. E., Schweizter, M. A., Clark, J. M., Torbenson, M. S., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-608oc · Cited by 210
Serum cytokine and soluble cytokine receptor levels in patients with non‐alcoholic steatohepatitis
Abiru, S., Migita, K., Maeda, Y., Daikoku, M., Ito, M., Ohata, K., Nagaoka, S., Matsumoto, T., Takii, Y., Kusumoto, K., et al. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01191.x · Cited by 209
Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
Hyogo, H., Tazuma, S., Arihiro, K., Iwamoto, K., Nabeshima, Y., Inoue, M., Ishitobi, T., Nonaka, M., & Chayama, K. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.030 · Cited by 206
Recruitment of lymphocytes to the human liver
Lalor, P. F., Shields, P., Grant, A. J., & Adams, D. H. (2002) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2002.01062.x · Cited by 204
Apoptosis in alcoholic and nonalcoholic steatohepatitis
Feldstein, A. (2005) · Frontiers in Bioscience · doi:10.2741/1765 · Cited by 203
Increased production of sonic hedgehog by ballooned hepatocytes
Rangwala, F., Guy, C. D., Lu, J., Suzuki, A., Burchette, J. L., Abdelmalek, M. F., Chen, W., & Diehl, A. M. (2011) · The Journal of Pathology · doi:10.1002/path.2888 · Cited by 201
Nonalcoholic Steatohepatitis in Children: A Multicenter Clinicopathological Study†
Carter-Kent, C., Yerian, L. M., Brunt, E. M., Angulo, P., Kohli, R., Ling, S. C., Xanthakos, S. A., Whitington, P. F., Charatcharoenwitthaya, P., Yap, J., et al. (2009) · Hepatology · doi:10.1002/hep.23133 · Cited by 201
Toll-Like Receptor 9 Inhibition Confers Protection From Liver Ischemia–Reperfusion Injury
Bamboat, Z. M., Balachandran, V. P., Ocuin, L. M., Obaid, H., Plitas, G., & DeMatteo, R. P. (2010) · Hepatology · doi:10.1002/hep.23365 · Cited by 199
Patel, D. N., King, C. A., Bailey, S. R., Holt, J. W., Venkatachalam, K., Agrawal, A., Valente, A. J., & Chandrasekar, B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703250200 · Cited by 197
Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis
Ilan, Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i21.2609 · Cited by 196
Morrison, E. D., Brandhagen, D. J., Phatak, P. D., Barton, J. C., Krawitt, E. L., El-Serag, H. B., Gordon, S. C., Galan, M. V., Tung, B. Y., Ioannou, G. N., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-8-200304150-00008 · Cited by 191
Pathways underlying iron accumulation in human nonalcoholic fatty liver disease
Aigner, E., Theurl, I., Theurl, M., Lederer, D., Haufe, H., Dietze, O., Strasser, M., Datz, C., & Weiss, G. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1374 · Cited by 190
Nath, B., Levin, I., Csak, T., Petrasek, J., Mueller, C., Kodys, K., Catalano, D., Mandrekar, P., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24256 · Cited by 190
Park, O., Jeong, W.-I., Wang, L., Wang, H., Lian, Z.-X., Gershwin, E. M., & Gao, B. (2009) · Hepatology · doi:10.1002/hep.22813 · Cited by 189
Constitutional telomerase mutations are genetic risk factors for cirrhosis
Calado, R. T., Brudno, J., Mehta, P., Kovacs, J. J., Wu, C., Zago, M. A., Chanock, S. J., Boyer, T. D., & Young, N. S. (2011) · Hepatology · doi:10.1002/hep.24173 · Cited by 188
Kahn, S. E., Zinman, B., Haffner, S. M., O’Neill, M. C., Kravitz, B. G., Yu, D., Freed, M. I., Herman, W. H., Holman, R. R., Jones, N. P., et al. (2006) · Diabetes · doi:10.2337/db06-0116 · Cited by 187
Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study
Rallidis, L. S., Drakoulis, C. K., & Parasi, A. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.008 · Cited by 181
Harada, K., Shimoda, S., Sato, Y., Isse, K., Ikeda, H., & Nakanuma, Y. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03947.x · Cited by 180
CHEN, Q. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06640.x · Cited by 179
Hug, H., Strand, S., Grambihler, A., Galle, J., Hack, V., Stremmel, W., Krammer, P. H., & Galle, P. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28191 · Cited by 178
Georgescu, E. F., Ionescu, R., Niculescu, M., Mogoanta, L., & Vancica, L. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.942 · Cited by 177
Imamura, M., Ogawa, T., Sasaguri, Y., Chayama, K., & Ueno, H. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.005 · Cited by 177
Adams, P. D. (2007) · Gene · doi:10.1016/j.gene.2007.04.020 · Cited by 176
Tahashi, Y., Matsuzaki, K., Date, M., Yoshida, K., Furukawa, F., Sugano, Y., Matsushita, M., Himeno, Y., Inagaki, Y., & Inoue, K. (2002) · Hepatology · doi:10.1053/jhep.2002.30083 · Cited by 176
Targher, G., Bertolini, L., Rodella, S., Zoppini, G., Scala, L., Zenari, L., & Falezza, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02527.x · Cited by 172
Histopathology of Non-Alcoholic Fatty Liver Disease
Brunt, E. M. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.008 · Cited by 172
Ikeda, K., Wakahara, T., Wang, Y. Q., Kadoya, H., Kawada, N., & Kaneda, K. (1999) · Hepatology · doi:10.1002/hep.510290640 · Cited by 167
Inflammatory signaling and cellular senescence
Ren, J., Pan, J., Lu, Y.-P., Sun, P., & Han, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.011 · Cited by 165
Yang, S., Koteish, A. A., Lin, H., Huang, J., Roskams, T., Dawson, V. L., & Diehl, A. M. (2004) · Hepatology · doi:10.1002/hep.20082 · Cited by 165
O'Shea, D., Cawood, T. J., O'Farrelly, C., & Lynch, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008660 · Cited by 162
Apoptosis and necrosis in liver disease
Jaeschke, H., Gujral, J. S., & Bajt, M. L. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0906.x · Cited by 161
Nuti, S., Rosa, D., Valiante, N. M., Saletti, G., Caratozzolo, M., Dellabona, P., Barnaba, V., & Abrignani, S. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11<3448::aid-immu3448>3.0.co;2-5 · Cited by 161
Uhrig, A., Banafsche, R., Kremer, M., Hegenbarth, S., Hamann, A., Neurath, M., Gerken, G., Limmer, A., & Knolle, P. A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0604332 · Cited by 161
Miura, K., Seki, E., Ohnishi, H., & Brenner, D. A. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/362847 · Cited by 160
Peribiliary myofibroblasts in biliary type liver fibrosis
Kinnman, N., & Housset, C. (2002) · Frontiers in bioscience · doi:10.2741/a790 · Cited by 160
Svegliati‐Baroni, G., Saccomanno, S., Van Goor, H., Jansen, P., Benedetti, A., & Moshage, H. (2001) · Liver · doi:10.1034/j.1600-0676.2001.210101.x · Cited by 160
Zein, C. O., Lopez, R., Fu, X., Kirwan, J. P., Yerian, L. M., McCullough, A. J., Hazen, S. L., & Feldstein, A. E. (2012) · Hepatology · doi:10.1002/hep.25778 · Cited by 160
Nonalcoholic Fatty Liver Disease: Current Issues and Novel Treatment Approaches
Lomonaco, R., Sunny, N. E., Bril, F., & Cusi, K. (2013) · Drugs · doi:10.1007/s40265-012-0004-0 · Cited by 158
Volkmann, X., Fischer, U., Bahr, M. J., Ott, M., Lehner, F., MacFarlane, M., Cohen, G. M., Manns, M. P., Schulze‐Osthoff, K., & Bantel, H. (2007) · Hepatology · doi:10.1002/hep.21846 · Cited by 156
Wang, Y., Ausman, L. M., Russell, R. M., Greenberg, A. S., & Wang, X. (2008) · Journal of Nutrition · doi:10.1093/jn/138.10.1866 · Cited by 156
The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
Seo, Y. S., & Shah, V. H. (2012) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2012.18.4.337 · Cited by 151
Role of TLR9 in hepatic stellate cells and experimental liver fibrosis
Gäbele, E., Mühlbauer, M., Dorn, C., Weiß, T. S., Froh, M., Schnabl, B., Wiest, R., Schölmerich, J., Obermeier, F., & Hellerbrand, C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.096 · Cited by 150
Wei, Y., Wang, D., Gentile, C. L., & Pagliassotti, M. J. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0142-1 · Cited by 147
Brun, P., Castagliuolo, I., Pinzani, M., Palù, G., & Martines, D. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00537.2004 · Cited by 147
Curbishley, S. M., Eksteen, B., Gladue, R. P., Lalor, P., & Adams, D. H. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62060-3 · Cited by 141
Kudo, S., Matsuno, K., Ezaki, T., & Ogawa, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.777 · Cited by 141
Cellular senescence: hot or what?
Evan, G. I., & di Fagagna, F. D. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.009 · Cited by 140
Chemokines in the immunopathogenesis of hepatitis C infection #
Heydtmann, M., & Adams, D. (2008) · Hepatology · doi:10.1002/hep.22763 · Cited by 138
Musso, G., Gambino, R., Michieli, F. D., Durazzo, M., Pagano, G., & Cassader, M. (2008) · Hepatology · doi:10.1002/hep.22142 · Cited by 137
Koca, S. S., Bahçecioğlu, İ. H., Poyrazoğlu, O. K., Özercan, İ. H., Şahin, K., & Üstündağ, B. (2007) · Inflammation · doi:10.1007/s10753-007-9053-z · Cited by 137
Regulation and pro‐inflammatory function of interleukin‐17 family cytokines
Dong, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00709.x · Cited by 136
Higashiyama, R., Moro, T., Nakao, S., Mikami, K., Fukumitsu, H., Ueda, Y., Ikeda, K., Adachi, E., Bou–Gharios, G., Okazaki, I., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.006 · Cited by 134
Leukocyte adhesion in the liver: Distinct adhesion paradigm from other organs
Lee, W., & Kubes, P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.005 · Cited by 133
Mitochondria, telomeres and cell senescence
Passos, J. F., & von Zglinicki, T. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.04.006 · Cited by 133
Kruglov, E. A., Nathanson, R. A., Nguyễn, T. T., & Dranoff, J. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00308.2005 · Cited by 132
Tajiri, K., Shimizu, Y., Tsuneyama, K., & Sugiyama, T. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32831bc3d6 · Cited by 127
Bechmann, L. P., Gieseler, R. K. H., Sowa, J., Kahraman, A., ERHARD, J., Wedemeyer, I., Emons, B., Jochum, C., Feldkamp, T., Gerken, G., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2010.02248.x · Cited by 127
Mechanisms and clinical implications of hepatocyte lipoapoptosis
Cazanave, S. C., & Gores, G. J. (2010) · Clinical Lipidology · doi:10.2217/clp.09.85 · Cited by 126
Elinav, E., Pappo, O., Sklair-Levy, M., Margalit, M., Shibolet, O., Gomori, M. J., Alper, R., Thalenfeld, B. E., Engelhardt, D., Rabbani, E., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1950 · Cited by 123
Kahraman, A., Schlattjan, M., Kocabayoglu, P., Yildiz-Meziletoglu, S., Schlensak, M., Fingas, C. D., Wedemeyer, I., Marquitan, G., Gieseler, R. K. H., Baba, H. A., et al. (2009) · Hepatology · doi:10.1002/hep.23253 · Cited by 123
Hartmann, P., Haimerl, M., Mazagova, M., Brenner, D. A., & Schnabl, B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.099 · Cited by 123
Nelson, J. E., Bhattacharya, R., Lindor, K. D., Chalasani, N., Raaka, S., Heathcote, J., Miskovsky, E. P., Shaffer, E. A., Rulyak, S. J., & Kowdley, K. V. (2007) · Hepatology · doi:10.1002/hep.21742 · Cited by 122
Kupffer Cell Aggregation and Perivenular Distribution in Steatohepatitis
Lefkowitch, J. H., Haythe, J. H., & Regent, N. (2002) · Modern Pathology · doi:10.1097/01.mp.0000019579.30842.96 · Cited by 122
Adams, L. A., Crawford, D. H., Stuart, K. A., House, M. J., Pierre, T. G. S., Webb, M., Ching, H. L., Kava, J., Bynevelt, M., MacQuillan, G. C., et al. (2014) · Hepatology · doi:10.1002/hep.27662 · Cited by 121
Petrasek, J., Dolganiuc, A., Csák, T., Kurt‐Jones, E. A., & Szabó, G. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.020 · Cited by 120
Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression
Farrell, G. C., Larter, C. Z., Hou, J. Y., Zhang, R. H., Yeh, M. M., Williams, J., Dela Peňa, A., Francisco, R., Osvath, S. R., Brooling, J., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05785.x · Cited by 120
Zhang, X., Xu, A., Chung, S. K., Cresser, J., Sweeney, G., Wong, R. L. C., Lin, A., & Lam, K. S. L. (2011) · Diabetes · doi:10.2337/db10-0650 · Cited by 120
Immune Interactions in Hepatic Fibrosis
Holt, A. P., Salmon, M., Buckley, C. D., & Adams, D. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.002 · Cited by 119
Su, Q., Tsai, J., Xu, E., Qiu, W., Bereczki, E., Sántha, M., & Adeli, K. (2009) · Hepatology · doi:10.1002/hep.22960 · Cited by 118
Aravinthan, A., Pietrosi, G., Hoare, M., Jupp, J., Marshall, A., Verrill, C., Davies, S., Bateman, A., Sheron, N., Allison, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072904 · Cited by 117
Liao, W., Hui, T. Y., Young, S. G., & Davis, R. A. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300020-jlr200 · Cited by 117
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans
Efsen, E., Grappone, C., DeFranco, R., Milani, S., Romanelli, R. G., Bonacchi, A., Caligiuri, A., Failli, P., Annunziato, F., Pagliai, G., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00065-x · Cited by 116
Sasaki, M., Miyakoshi, M., Sato, Y., & Nakanuma, Y. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.008 · Cited by 115
Prognostic Value of Plasma Endotoxin Levels in Patients with Cirrhosis
Chan, C. C., Hwang, S. J., Lee, F. Y., Wang, S. S., Chang, F. Y., Li, C. P., Chu, C. J., Lu, R. H., & Lee, S. D. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011206 · Cited by 113
Yokohama, S., Tokusashi, Y., Nakamura, K., Tamaki, Y., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Aoshima, M., Miyokawa, N., et al. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i2.322 · Cited by 111
Roles of liver innate immune cells in nonalcoholic fatty liver disease
Zhan, Y.-T., & An, W. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i37.4652 · Cited by 111
Martin‐Armas, M., Simón-Santamaría, J., Pettersen, I., Moens, U. L., Smedsrød, B. H., & Sveinbjørnsson, B. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.020 · Cited by 108
Marí, M., Colell, A., Morales, A., Caballero, F., Moles, A., Fernández, A., Terrones, O., Basáñez, G., Antonsson, B. E., García‐Ruiz, C., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.073 · Cited by 107
Scott, M. J., & Billiar, T. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803905200 · Cited by 106
Malaguarnera, L., Rosa, M. D., Zambito, A. M., dell’Ombra, N., Nicoletti, F., & Malaguarnera, M. (2006) · Gut · doi:10.1136/gut.2005.075697 · Cited by 105
Kono, H., Karmarkar, D., Iwakura, Y., & Rock, K. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902485 · Cited by 101
Deng, Y.-R., Ma, H.-D., Tsuneyama, K., Yang, W., Wang, Y., Lu, F.-T., Liu, P., Liu, P., He, X.-S., Diehl, A. M., et al. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.07.008 · Cited by 100
Mac the knife? Macrophages– the double-edged sword of hepatic fibrosis
Friedman, S. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23928 · Cited by 99
Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality
Berry, D. A., Wathen, J. K., & Newell, M. (2009) · Clinical Trials · doi:10.1177/1740774508101279 · Cited by 90
Yoneda, M., Nozaki, Y., Endo, H., Mawatari, H., Iida, H., Fujita, K., Yoneda, K., Takahashi, H., Kirikoshi, H., Inamori, M., et al. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0771-y · Cited by 89
Clément, S., Juge-Aubry, C. E., Sgroi, A., Conzelmann, S., Pazienza, V., Pittet-Cuenod, B. M., Meier, C. A., & Negro, F. (2008) · Hepatology · doi:10.1002/hep.22404 · Cited by 88
Gerss, J., & Köpcke, W. (2009) · PubMed · Cited by 87
Cosgrove, B. D., Cheng, C., Pritchard, J. R., Stolz, D. B., Lauffenburger, D. A., & Griffith, L. G. (2008) · Hepatology · doi:10.1002/hep.22335 · Cited by 87
Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease
Attar, B. M., & Thiel, D. H. V. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/481893 · Cited by 85
Potential Role of Chitotriosidase Gene in Nonalcoholic Fatty Liver Disease Evolution
Malaguarnera, L., Rosa, M. D., Zambito, A. M., dell'Ombra, N., Marco, R. D., & Malaguarnera, M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00680.x · Cited by 85
D′Albuquerque, L. A. C., Gonzalez, A. M., Wahle, R. C., Souza, E. D. O., Mancero, J. M. P., & Silva, A. D. O. E. (2008) · Liver Transplantation · doi:10.1002/lt.21472 · Cited by 84
Ikeyama, S., Wang, X., Li, J., Podlutsky, A. J., Martindale, J. L., Kokkonen, G. C., van Huizen, R., Gorospe, M., & Holbrook, N. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300677200 · Cited by 83
Moroorange juice prevents fatty liver in mice
Salomone, F., Volti, G. L., Titta, L., Puzzo, L., Barbagallo, I., Delia, F. L., Zelber-Sagi, S., Malaguarnera, M., Pelicci, P. G., Giorgio, M., et al. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i29.3862 · Cited by 83
Human Polynucleotide Phosphorylase ( hPNPase old-35 )
Sarkar, D., Lebedeva, I. V., Emdad, L., Kang, D.-C., Baldwin, A. S., & Fisher, P. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1772 · Cited by 77
Factors accounting for high ferritin levels in obesity
Lecube, A., Hernández, C., Pelegrí, D., & Simó, R. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.154 · Cited by 75
Lymphocyte–hepatic stellate cell proximity suggests a direct interaction
Muhanna, N., Horani, A., Doron, S., & Safadi, R. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03353.x · Cited by 74
Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet
Flowers, M. T., Groen, A. K., Oler, A. T., Keller, M. P., Choi, Y., Schueler, K. L., Richards, O. C., Hong, L., Miyazaki, M., Kuipers, F., et al. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600203-jlr200 · Cited by 73
Yaʼacov, A. B., Mizrahi, M., Shabat, Y., Lalazar, G., Adar, T., Wong, V., Muller, B. D., Rawlin, G., & Ilan (2012) · Journal of Inflammation Research · doi:10.2147/jir.s35227 · Cited by 73
Nakajima, T., Moriguchi, M., Katagishi, T., Sekoguchi, S., Nishikawa, T., Takashima, H., Kimura, H., Minami, M., Itoh, Y., Kagawa, K., et al. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01178.x · Cited by 73
Mechanisms of Disease Progression in NASH
Bohinc, B. N., & Diehl, A. M. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.05.002 · Cited by 69
Saturated free fatty acid, palmitic acid, induces apoptosis in fetal hepatocytes in culture
Ji, J. F., Zhang, L., Wang, P., Mu, Y., Zhu, X., Wu, Y., Yu, H., Zhang, B., Chen, S., & Sun, X.-Z. (2005) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2005.02.003 · Cited by 68
Maher, J. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38178 · Cited by 67
Ilan, Y., Zigmond, E., Lalazar, G., Dembinsky, A. V., Yaʼacov, A. B., Hemed, N., Kasis, I., Axelrod, E., Zolotarov, L., Klein, A., et al. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9323-7 · Cited by 67
Sparna, T., Rétey, J., Schmich, K., Albrecht, U., Naumann, K., Gretz, N., Fischer, H., Bode, J. G., & Merfort, I. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-226 · Cited by 66
Grinko, I., Geerts, A. E., & Wisse, E. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80204-5 · Cited by 64
Hironaka, K., Sakaida, I., Matsumura, Y., Kaino, S., Miyamoto, K., & Okita, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1910 · Cited by 64
Role for hedgehog pathway in regulating growth and function of invariant NKT cells
Syn, W., Witek, R. P., Curbishley, S. M., Jung, Y., Choi, S. S., Enrich, B., Omenetti, A., Agboola, K. M., Fearing, C. M., Tilg, H., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838890 · Cited by 61
Tilg, H. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791208929 · Cited by 60
Busconi, L., Bauer, J. W., Tumang, J. R., Laws, A., Mesires, K. P., Tabor, A. S., Lau, C. M., Corley, R. B., Rothstein, T. L., Lund, F. E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7397 · Cited by 59
Brenner, D. A., Seki, E., Taura, K., Kisseleva, T., Deminicis, S., Iwaisako, K., Inokuchi, S., Schnabl, B., Oesterreicher, C., Paik, Y. H., et al. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00814.x · Cited by 55
Tan, M., Feng, H., Xu, X., Chisolm, G. M., & Cui, M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.191585 · Cited by 54
Skoien, R., Richardson, M. M., Jonsson, J. R., Powell, E. E., Brunt, E. M., Neuschwander‐Tetri, B. A., Bhathal, P. S., Dixon, J. B., O’Brien, P. E., Tilg, H., et al. (2013) · Liver International · doi:10.1111/liv.12100 · Cited by 54
Self-citationCell death and nonalcoholic steatohepatitis: where is ballooning relevant?
Machado, M. V., & Cortez‐Pinto, H. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.16 · Cited by 53
Extra- and intracellular innate immune recognition in endothelial cells
Hippenstiel, S., Eitel, J., Suttorp, N., & Opitz, B. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-12-0694 · Cited by 53
The role of CD11c+ hepatic dendritic cells in the induction of innate immune responses
Shu, S.-A., Lian, Z.-X., Chuang, Y.-H., Yang, G.-X., Moritoki, Y., Comstock, S. S., Zhong, R.-Q., Ansari, A. A., Liu, Y. J., & Gershwin, M. E. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03419.x · Cited by 52
Fructose-induced hepatic gluconeogenesis: Effect of l-carnitine
Rajasekar, P., & Anuradha, C. V. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.12.010 · Cited by 51
Wanninger, J., Neumeier, M., Hellerbrand, C., Schacherer, D., Bauer, S., Weiß, T. S., Huber, H., Schäffler, A., Aslanidis, C., Schölmerich, J., et al. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.11.001 · Cited by 50
Xu, C. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i33.4504 · Cited by 48
Non-alcoholic fatty liver disease: is iron relevant?
O’Brien, J., & Powell, L. W. (2011) · Hepatology International · doi:10.1007/s12072-011-9304-9 · Cited by 48
Self-citationEquitani, F., Fernández‐Real, J. M., MENICHELLA, G., Koch, M., Calvani, M., Nobili, V., Mingrone, G., & Manco, M. (2007) · Diabetes Care · doi:10.2337/dc07-0939 · Cited by 46
Csák, T., Dolganiuc, A., Kodys, K., Nath, B., Petrášek, J., Bala, S., Lippai, D., & Szabó, G. (2011) · Hepatology · doi:10.1002/hep.24301 · Cited by 45
Insulin resistance in non-alcoholic steatohepatitis
Cömert, B., Mas, M. R., Erdem, H., Dinç, A., Saǧlamkaya, U., Ciğerim, M., Kuzhan, O., Unal, T., & Kocabalkan, F. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80091-8 · Cited by 44
Large cell change of hepatocytes in chronic viral hepatitis represents a senescent-related lesion
Ikeda, H., Sasaki, M., Sato, Y., Harada, K., Zen, Y., Mitsui, T., & Nakanuma, Y. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.06.009 · Cited by 44
Hemochromatosis gene and nonalcoholic fatty liver disease: A systematic review and meta-analysis
Hernáez, R., Yeung, E. H., Clark, J. M., Kowdley, K. V., Brancati, F. L., & Kao, W. H. L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.013 · Cited by 43
Nutritional related liver disease: targeting the endoplasmic reticulum stress
Kammoun, H. L., Hainault, I., Ferré, P., & Foufelle, F. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833189db · Cited by 40
Lecube, A., Hernández, C., & Simó, R. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.972 · Cited by 36
Nolan, J. P., & Leibowitz, A. I. (1978) · Gastroenterology · doi:10.1016/s0016-5085(19)31709-3 · Cited by 35
Induction of Immunological Tolerance by Oral Anti-CD3
da Cunha, A. P., & Weiner, H. L. (2011) · Clinical and Developmental Immunology · doi:10.1155/2012/425021 · Cited by 34
Aghazadeh, S., & Yazdanparast, R. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.08.014 · Cited by 30
Hornsby, P. J. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0723-6 · Cited by 29
Insulin resistance influences iron metabolism and hepatic steatosis in type II diabetes
Viganò, M., Vergani, A., Trombini, P., Pozzi, M., Paleari, F., & Piperno, A. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70193-4 · Cited by 29
Moro orange juice prevents fatty liver in mice
Federico, F., Salamone, Giovanni, G., Li, Volti, Lucilla, Titta, Lidia, Puzzo, Ignazio, et al. (2012) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 27
Thiazolidinediones for the Treatment in NASH: Sustained Benefit After Drug Discontinuation?
Argo, C. K., Iezzoni, J. C., Al‐Osaimi, A. M. S., & Caldwell, S. H. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31818f4fc2 · Cited by 26
Romics, L., Mandrekar, P., Kodys, K., Velayudham, A., Drechsler, Y., Dolganiuc, A., & Szabó, G. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000167744.60838.4a · Cited by 24
Clinical Spectrum and Therapy of Non-Alcoholic Steatohepatitis
Day, C. P. (2012) · Digestive Diseases · doi:10.1159/000341128 · Cited by 24
Nash, insulin resistance and iron
MACHADO, M., & CORTEZ‐PINTO, H. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01394.x · Cited by 18
Fotiadu, A., Gagalis, A., Akriviadis, E. A., Kotoula, V., Sinakos, E., Karkavelas, G., & Hytiroglou, P. (2009) · Pathology International · doi:10.1111/j.1440-1827.2009.02489.x · Cited by 15
Síndrome de Muckle-Wells em quatro membros de uma família
Pereira, A. F. J. R., Pereira, L. B., do Vale, E. C. S., & Tanure, L. A. (2010) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962010000600022 · Cited by 11
Senn, J. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.a109.513304 · Cited by 8
Cited by
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Non-alcoholic fatty liver disease: An expanded review
Benedict, M., & Zhang, X. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i16.715 · Cited by 751
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Rada, P., González-Rodríguez, Á., García-Monzón, C., & Valverde, Á. M. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03003-w · Cited by 518
Metadata
- Authors
- Peverill, W., Powell, L., & Skoien, R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2014-05-14
- Volume
- 15
- Issue
- 5
- Pages
- 8591-8638
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2039636142
- Cited by
- 376
- References
- 371
- FWCI
- 16.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.